Pharmaceutical Tablet Supply – Oral Contraceptive Formulation

The contract pertains to the manufacture and supply of 6 pack groups, each comprising 6 cycles of 28 tablets of Levonorgestrel and Ethinyl Estradiol Tablets, USP, resulting in a total quantity of 1,008 tablets. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, governed by NAICS code 325412, which classifies the production of pharmaceutical preparations. The solicitation was posted on May 10, 2026, with a response deadline of May 18, 2026, indicating a tight turnaround for interested parties to submit proposals. The place of performance and specific office address are not detailed, but the work is linked to U.S. defense medical procurement channels. The contract is exclusively for oral contraceptive formulation, requiring strict adherence to USP standards for active ingredients and packaging integrity. All deliveries must align with the specified pack group structure to ensure compliance with military healthcare distribution and dosing protocols.